No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
MedPacto, Inc. is a South Korean biopharmaceutical company specializing in the research and development of novel therapeutic solutions for oncology and autoimmune conditions. The firm's pipeline includes several key drug candidates: ME-1601mAb, an investigational treatment designed to target BSP1 for various cancers; MS-1601A, which addresses both cancerous and autoimmune diseases by targeting TRG1; and vactosertib, a therapeutic candidate aimed at solid tumors. MedPacto is headquartered in Seoul, South Korea.
www.medpacto.comNo one on the platform currently holds 235980.KQ.
No tracked institution reports a position in 235980.KQ as of their last filing.
No one on the platform has traded 235980.KQ yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 235980.KQMedPacto, Inc. | $2740.00 | +0.37% | $93.9B | — |
| 002630.KSORIENT BIO Inc. | $913.00 | +8.69% | $54.1B | — |
| 011000.KSGeneOne Life Science, Inc. | $2670.00 | -7.45% | $48.4B | — |
| 038290.KQMacrogen, Inc. | $11750.00 | -0.42% | $127.4B | — |
| 048530.KQiNtRON Biotechnology, Inc. | $2860.00 | -1.38% | $88.4B | — |
| 083790.KQCG Invites Co., Ltd. | $948.00 | -2.17% | $72.9B | — |
| 092040.KQAmicogen, Inc. | $833.00 | +1.34% | $47.4B | — |
Source: Financial Modeling Prep · peers by sector/industry